Photocure ASA (PHO):企業の財務・戦略的SWOT分析

◆英語タイトル:Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2718
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Photocure ASA (PHO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Photocure ASA (Photocure) is a specialty pharmaceutical company with focus on cancer and dermatology. It develops and markets pharmaceuticals and medical devices for the diagnosis and treatment of various types of cancer and precancerous conditions based on its photodynamic technology. The company’s flagship product Hexvix is an optical imaging agent used for the detection of bladder cancer. The company offers this product under the name Cysview in the US for the use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder. Photocure’s major product candidates include Cevira (in Phase II studies) for the treatment of HPV infection and precancerous lesions of the cervix and Visonac (in Phase II studies) for the treatment of moderate to severe acne. The company sells its product in Sweden, Norway, Germany, France and the US, Canada and Australia/New Zealand. Photocure is headquartered in Oslo, Norway.

Photocure ASA Key Recent Developments

Jun 26,2018: Photocure Announces Resignation Of Kjetil Hestdal As CEO
May 23,2018: Photocure: Results for the first quarter of 2018
Feb 27,2018: Photocure: Results for the fourth quarter of 2017
Nov 07,2017: Photocure: Results for the third quarter of 2017
Aug 23,2017: Photocure: Results for second quarter and first half year of 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Photocure ASA – Key Facts 6
Photocure ASA – Key Employees 7
Photocure ASA – Key Employee Biographies 8
Photocure ASA – Major Products and Services 9
Photocure ASA – History 10
Photocure ASA – Company Statement 12
Photocure ASA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Photocure ASA – Business Description 15
Business Segment: Commercial Franchise 15
Overview 15
Performance 15
Business Segment: Development Portfolio 15
Overview 15
Geographical Segment: Nordic countries 16
Performance 16
Geographical Segment: Partner countries Europe 16
Performance 16
Geographical Segment: Partner countries Rest of World 16
Performance 16
Geographical Segment: The US 16
Performance 16
Photocure ASA – Corporate Strategy 17
Photocure ASA – SWOT Analysis 18
SWOT Analysis – Overview 18
Photocure ASA – Strengths 18
Photocure ASA – Weaknesses 19
Photocure ASA – Opportunities 20
Photocure ASA – Threats 21
Photocure ASA – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Photocure ASA, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
May 23, 2018: Photocure: Results for the first quarter of 2018 33
Feb 27, 2018: Photocure: Results for the fourth quarter of 2017 34
Nov 07, 2017: Photocure: Results for the third quarter of 2017 35
Aug 23, 2017: Photocure: Results for second quarter and first half year of 2017 36
May 23, 2017: Photocure: Results for the first quarter of 2017 37
May 16, 2017: Photocure: Presentation of results from the Blue Light Flexible Cystoscopy with Hexvix/Cysview phase 3 study 38
May 12, 2017: Phase 3 study investigating Blue Light Flexible Cystoscopy with Cysview in surveillance setting meets primary endpoint 39
May 05, 2017: Jeremy Bahr Appointed Chief Business Officer 40
Apr 28, 2017: Photocure Appoints Three New Members to Its Board of Directors 41
Apr 05, 2017: Photocure Provides Strategic Update 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Photocure ASA, Key Facts 6
Photocure ASA, Key Employees 7
Photocure ASA, Key Employee Biographies 8
Photocure ASA, Major Products and Services 9
Photocure ASA, History 10
Photocure ASA, Subsidiaries 13
Photocure ASA, Key Competitors 22
Photocure ASA, Ratios based on current share price 23
Photocure ASA, Annual Ratios 24
Photocure ASA, Annual Ratios (Cont...1) 25
Photocure ASA, Annual Ratios (Cont...2) 26
Photocure ASA, Interim Ratios 28
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Photocure ASA, Recent Deals Summary 32
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

List of Figures
Photocure ASA, Performance Chart (2013 - 2017) 27
Photocure ASA, Ratio Charts 29
Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Photocure ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

★海外企業調査レポート[Photocure ASA (PHO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shiseido Company, Limited:企業の戦略・SWOT・財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務情報
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …
  • Celsense Inc-医療機器分野:企業M&A・提携分析
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as …
  • Foshan Electrical and Lighting Co Ltd (000541):企業の財務・戦略的SWOT分析
    Summary Foshan Electrical and Lighting Co Ltd (Foshan Lighting) is a manufacturer and marketer of lighting products and electrical equipment. The company's products include home lighting, LED lighting products, traditional lighting and fixtures, vehicle lighting products, and electrical supports. It …
  • UAC of Nigeria PLC:企業の戦略・SWOT・財務情報
    UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report Summary UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Public Financial Holdings Ltd (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Seven & i Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CropEnergies AG (CE2):企業の財務・戦略的SWOT分析
    CropEnergies AG (CE2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Eaton Corporation plc:戦略・SWOT・企業財務分析
    Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zain Group:企業の戦略・SWOT・財務情報
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kohlberg Kravis Roberts & Co LP:企業のM&A・事業提携・投資動向
    Kohlberg Kravis Roberts & Co LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kohlberg Kravis Roberts & Co LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Ascoma Group:企業の戦略・SWOT・財務情報
    Ascoma Group - Strategy, SWOT and Corporate Finance Report Summary Ascoma Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target valida …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • China Petroleum & Chemical Corp (600028):石油・ガス:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Costain Group Plc (COST):企業の財務・戦略的SWOT分析
    Costain Group Plc (COST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Johnson Controls International Plc (JCI):企業の財務・戦略的SWOT分析
    Johnson Controls International Plc (JCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ono Pharmaceutical Co Ltd (4528):医療機器:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • DCP Midstream LP (DCP):石油・ガス:M&Aディール及び事業提携情報
    Summary DCP Midstream LP (DCP), formerly DCP Midstream Partners, LP, is a midstream energy company. It gathers, compresses, treats, and processes natural gas; and produces and markets natural gas liquids (NGL). The company also fractionates NGLs, and recovers and sells condensate. DCP transports NGL …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆